# ClinicalTrials.gov record NCT00225420

> PeptideScanner retained ClinicalTrials.gov record NCT00225420 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-06-01, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00225420-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-06-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00225420-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00225420-leuprolide-v1.json
- Content SHA-256: `02a04347548cd82cd3fb468d693fca78f2d48dfcc382c6dfcf2860d4bf0a24ab`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00225420 ([`ctg-observation-nct00225420-2017-06-01-70f6c76b363f`](#source-ctg-observation-nct00225420-2017-06-01-70f6c76b363f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00225420 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-06-01, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00225420-2017-06-01-70f6c76b363f`](#source-ctg-observation-nct00225420-2017-06-01-70f6c76b363f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00225420 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-06-01, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00225420-2017-06-01-70f6c76b363f`](#source-ctg-observation-nct00225420-2017-06-01-70f6c76b363f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00225420-2017-06-01-70f6c76b363f`](#source-ctg-observation-nct00225420-2017-06-01-70f6c76b363f))

## Sources

<a id="source-ctg-observation-nct00225420-2017-06-01-70f6c76b363f"></a>
- **ClinicalTrials.gov record NCT00225420 · retained source version 2017-06-01:70f6c76b363f2427e23c77769f30484e2eb769fb8819581d7079908fb17018b8** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00225420) (`ctg-observation-nct00225420-2017-06-01-70f6c76b363f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00225420." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00225420-leuprolide-v1.json SHA-256: 02a04347548cd82cd3fb468d693fca78f2d48dfcc382c6dfcf2860d4bf0a24ab.